NPC at a Glance
NPC is a health policy research organization focused on the critical issues of evidence, the value of medicines for patients, and innovation...more
CER
Do stakeholders think comparative effectiveness research is having an impact on health care decision making? Which organizations are viewed as the leaders on prioritizing, funding, and conducting research? Download our new booklet to find out...more
Value of Rx
Recent NPC research has focused on defining the optimal role and value of pharmaceuticals in the evolving payment and delivery models...more
Individual Treatment Effects
Being "unique" can impact your health care treatments. Learn more about the challenges of individual treatment effects...more
RECENT NEWS
CER Tweets of the Week: New UMB Center of Excellence In CER, UIC College of Pharmacy Master’s in CER, PCORI in Lancet (January 19-23)
Comparative effectiveness research (CER) stakeholders tweeted about new educational opportunities regarding CER... moreCER Tweets of the Week: The Challenges of Gray-Zone Medicine, PCORI in the Congress Blog (January 12-16)
This week, comparative effectiveness research (CER) stakeholders tweeted multiple articles regarding CER and... more#TBT: Quality of Life, Innovation & Evidence Adoption
As part of our “Throwback Thursday” blog series, we’re taking a look at a topic that’s currently in the news and... moreCER Tweets of the Week: AcademyHealth Compares International CER, Resource Library on CER (January 5-9)
This week, comparative effectiveness research (CER) stakeholders tweeted about @AcademyHealth’s new paper... more
MAP to Review Quality Measures Under Consideration
The National Quality Forum’s (NQF) Measure Applications Partnership (MAP) will begin reviewing more than 200... moreWhich Plans Cover My Medicines? Will Marketplaces Be More Transparent?
Patient organizations and consumers have expressed concern about how challenging it is to determine whether... moreHave a Great Research Idea? We Might Have a Grant for That.
When we hear from a wide range of health care stakeholders, it provides us with different perspectives on issues... moreCDHPs: Challenges to Managing Workforce Health, Performance & Productivity
More employers are implementing consumer-directed health plans (CDHPs) as a way to lower their cost burden of... more
Biogen Idec and Gilead Sciences Join the National Pharmaceutical Council
Washington, D.C. (December 9, 2014)—The National Pharmaceutical Council (NPC) today welcomed two leading... moreImproving Patient Outcomes and Costs in an ACO Through Comprehensive Medication Therapy Management
Washington, D.C. (December 4, 2014)—A case study published in the December 2014 issue of the Journal of Managed... moreEisai’s David Martin Elected as National Pharmaceutical Council’s Chairman of the Board
Washington, D.C. (November 7, 2014)—The National Pharmaceutical Council (NPC) today announced that David J.... moreNational Pharmaceutical Council, Discern Health Examine Accountable Care Measures for Specialty Care and Innovative Treatment
Washington, DC (October 28, 2014)— Measuring the quality and cost of health care is an integral part of... more
Chain Drug Review – Commentary: “Health Care Outlook for 2015”
This commentary was originally published in the January 5, 2015 issue of Chain Drug Review.By: Dan Leonard,... moreNPC Comments on PCORI Proposal for Peer Review of Primary Research and Public Release of Research Findings
November 7, 2014Dr. Joe SelbyExecutive DirectorPatient-Centered Outcomes Research Institute1828 L St., NW, Suite... moreHealthcare Leadership Council & NPC Submit Comments to CMS on Access to Part D Data
March 7, 2014The Honorable Marilyn Tavenner, AdministratorCenters for Medicare & Medicaid ServicesU.S.... moreNPC Comments on CMS' Proposed Changes to Protected Classes
March 7, 2014Marilyn B. TavennerAdministratorCenters for Medicare & Medicaid ServicesU.S. Department of... more
Why are quality measures important? We asked health care thought leaders to tell us why.
Quality measurement, tied to financial incentives, is one of many approaches accountable care programs are using... moreAccess to Specialty Medications & Value-Based Insurance Design
Specialty medications have been making health care headlines because of their effectiveness and higher costs.... moreConsumer-Directed Health Plans
A unique survey of large employers sheds light on the strategies and best practices that they follow when... moreHealth Technology Assessments and Specialty Medications
David Grainger, senior director, global public policy, Eli Lilly and Company, says that there are often... moreCER Tweets of the Week: New UMB Center of Excellence In CER, UIC College of Pharmacy Master’s in CER, PCORI in Lancet (January 19-23)
Comparative effectiveness research (CER) stakeholders tweeted about new educational opportunities regarding CER... moreCER Tweets of the Week: The Challenges of Gray-Zone Medicine, PCORI in the Congress Blog (January 12-16)
This week, comparative effectiveness research (CER) stakeholders tweeted multiple articles regarding CER and... more#TBT: Quality of Life, Innovation & Evidence Adoption
As part of our “Throwback Thursday” blog series, we’re taking a look at a topic that’s currently in the news and... moreCER Tweets of the Week: AcademyHealth Compares International CER, Resource Library on CER (January 5-9)
This week, comparative effectiveness research (CER) stakeholders tweeted about @AcademyHealth’s new paper... moreNEWS FEEDS
PUBLICATION
Best Practices: Improving Patient Outcomes and Costs in an ACO Through Comprehensive Medication Therapy Management
This case study explores the important role that pharmacists can play in ensuring the optimal use of pharmaceuticals and improving patient outcomes in an ACO.
WEBINAR
Mind the Gap: Improving Quality Measurement in Accountable Care Systems
Back by popular demand: a conversation with three health care thought leaders on quality measurement!
